US 12161706
Cancer vaccines targeting BORIS and uses thereof
granted A61KA61K2039/5154A61K2039/5156
Quick answer
US patent 12161706 (Cancer vaccines targeting BORIS and uses thereof) held by Inovio Pharmaceuticals, Inc. expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/5154, A61K2039/5156, A61K2039/5158, A61K2039/53